市場調査レポート

薬物乱用検査市場(試験所用、医療POC、在宅用、雇用先、刑事司法)

Drugs of Abuse Testing Markets: Lab-Based, Professional POC, Home, Employment, & Criminal Justice Markets

発行 Kalorama Information 商品コード 309154
出版日 ページ情報 英文 150 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
薬物乱用検査市場(試験所用、医療POC、在宅用、雇用先、刑事司法) Drugs of Abuse Testing Markets: Lab-Based, Professional POC, Home, Employment, & Criminal Justice Markets
出版日: 2014年07月14日 ページ情報: 英文 150 Pages
概要

薬物乱用検査は、IVD検査における重要な成長カテゴリーであり、大手IVDベンダーが市場シェアを獲得しようと参入しています。医療従事者、雇用主、刑事司法、およびスポーツなどで、個人の行動や挙動、パフォーマンスに関する正しい判断をすることを目的とした包括的評価の一部として用いられています。

当レポートでは、薬物乱用検査市場の概要と動向、予測とともに、用途別、地域別市場、プロバイダーによる市場シェアなどをまとめています。

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 薬物乱用検査製品

  • 尿
  • 経口
  • 血液
  • 毛髪

第4章 薬物乱用検査市場および競合分析

  • 市場概要
  • 製品別市場分析
  • 用途別市場分析
    • 刑事司法
    • 試験所
      • 医療POC
      • 在宅OTC
  • 地域別市場分析
  • 競合分析

第5章 課題と動向

  • 技術的動向
  • 薬物検査と福祉受給者
  • 薬物乱用検査と技術市場
  • 新たな不法薬物
  • 薬物検査の粗悪化
  • 法規制上の課題
  • 業界統合
  • 薬物とスポーツ

第6章 業界における製造業者

付録:主要企業リスト

図表

目次
Product Code: KLI5295379

Drugs of Abuse is an important growth category in IVD testing with competitive participation by top IVD vendors for market share. Healthcare professionals, employers, criminal justice personnel, and sports use drug tests as part of a comprehensive evaluation of individuals to reach a correct decision regarding the individuals' actions, behaviors or performances. This report covers trends and markets in drugs of abuse testing. As part of its coverage, the report offers estimates and forecasts for drugs of abuse markets, and the following market segment estimates:

Market by Type of Sample (Urine, Oral, Blood, Hair)

Market by Application, including:

  • Employment
  • Criminal Justice
  • Lab-based IVD
  • Professional POC
  • Home OTC

Market by Region (US, EUR, ROW)

Market Share by Provider

The report's geographic scope is worldwide with information for specific geographical regions; world demographics;, and other general issues affecting the market The market summary includes market analysis by product and region and a competitive analysis of leading providers. Additionally, key company profiles are included. The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.

Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 12 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

A group of diversified companies is involved in the development or marketing of drugs of abuse testing and technology products. The market is considered evolving with growth opportunity. Drug abuse is a worldwide problem and it is growing. Key companies such as Roche Diagnostics, Abbott Diagnostics and Siemens Healthcare will likely maintain leading positions in the market through continued product innovation and strategic alliances and mergers.

Among the top and/or innovative competitors discussed within Corporate Profiles are:

  • 1st Step Detect Associates
  • Abbott Diagnostics
  • AccuTech
  • Alere
  • Alfa Scientific
  • Amedica Biotech
  • American Bio Medica
  • Atlas Link Biotech
  • Beckman Coulter
  • Biophor Diagnostics
  • Bio-Medical Products
  • Bio-Rad Laboratories
  • BioScan Screening Systems
  • Branan Medical Corp
  • Confirm Biosciences
  • DeVon Medical Products
  • IDenta Corp
  • Lifeloc Technologies
  • LifeSign
  • MAVAND Solutions
  • MedTest Dx
  • Mossman Associates
  • MP BioMedicals
  • Nano-Ditech Corp
  • OraSure
  • Ortho Clinical Diagnostics
  • Polymed Therapeutics
  • PreChek Bio
  • Princeton Biomedtech
  • Psychemedics
  • Randox Laboratories
  • Redwood Toxicology
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • UCP Biosciences

Additional Information

There are many different methods of testing for drugs. There is no single best method. In selecting the testing method that will produce the best analyses, three factors are considered:

  • The drug being tested
  • The type of specimen used for the test
  • The testing circumstances

Immunoassays

Immunoassays are common in clinical laboratories. Some of those most frequently used include latex agglutination tests, radioimmunoassay (RIA), fluorescence polarization, immunoassay (performed on the Abbott Tex and related instruments), and enzyme-multiplied immunoassay technique (EMIT), a trademark of the Syva Corporation. These tests are completely specific.

Latex Agglutination

Latex agglutination tests are examples of tests that can conveniently be performed on an occasional basis in a POL. They are too expensive for large-volume work, but require no instrumentation. Their use is generally confined to urine specimens.

Lateral Flow

Lateral flow tests also known as lateral flow immunochromatographic assays, are simple devices intended to detect the presence (or absence) of a target analyte in the sample (matrix) without the need for specialized and costly equipment, though many lab based applications exist that are supported by reading equipment. Typically, these tests are used for medical diagnostics either for home testing, point of care testing, or laboratory use. The technology is based on a series of capillary beds, such as pieces of porous paper or sintered polymer. Each of these elements has the capacity to transport fluid (e.g., urine) spontaneously.

Radioimmunoassay

Radioimmunoassay is usually a manual test. It is satisfactory for use on blood as well as other body fluids and is widely used in forensic toxicology laboratories.

Thin-Layer Chromatography

Thin-layer chromatography is well suited for simultaneous screening of urine specimens for hundreds of drugs. Results are qualitative only, and the test is not extremely sensitive. It is best used for testing specimens from hospital emergency rooms, but is not widely available because of the technical expertise required to perform the test. Drugs are extracted from the specimens to be tested, concentrated, and applied to the bottom of a strip of paper or other permeable material. The bottom of the strip is then immersed in a solvent inside a closed container. As the solvent travels up the paper, drugs are carried along at different rates and separated. After drying the chromagram, the drugs may be visualized as colored spots by spraying with various chemicals.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Scope and Methodology
  • Size and Growth of the Market
  • Key Issues and Trends Affecting Market
  • Leading Competitors

CHAPTER TWO: INTRODUCTION

  • Overview
  • Club Drugs
  • GHB
  • Rohypnol
  • Ketamine
  • Narcotic Abuse
  • Heroin
  • Narcotic Analgesics
  • Opium
  • Central Nervous System Depressant Abuse
  • Sedative-Hypnotic/Antianxiety Abuse
  • Alcohol Abuse
  • Central Nervous system Stimulants
  • Amphetamine and Amphetamine-Like Agents
  • Ecstasy
  • Cocaine Abuse
  • Marijuana Abuse
  • Psychedelic Agents
  • Tobacco
  • Inhalant Abuse
  • Steroid Abuse
  • Miscellaneous Drugs of Abuse
  • Salvia
  • Bath Salts
  • Khat
  • DXM
  • World Demographics
  • Prevalence and Number of Illicit Drug Users
  • Types of Specimens Used for Drugs of Abuse Testing
  • Urine
  • Oral
  • Blood
  • Hair
  • Sweat
  • Drugs of Abuse Testing Situations
  • Employment
  • Medical Screening
  • Legal
  • Sports
  • Methods of Testing for Drugs
  • Immunoassays
  • Latex Agglutination
  • Lateral Flow
  • Radioimmunoassay
  • Fluorescence Polarization Immunoassay
  • EMIT
  • Chromatography
  • Thin-Layer Chromatography
  • High-Pressure Liquid Chromatography
  • Gas Chromatography
  • Gas Chromatography/Mass Spectrometry

CHAPTER THREE: DRUGS OF ABUSE TEST PRODUCTS

  • Urine
  • Oral
  • Blood
  • Hair

CHAPTER FOUR: DRUGS OF ABUSE MARKET AND COMPETITOR ANALYSIS

  • Market Overview
  • Market Analysis by Product Type
  • Market Analysis by Setting
    • Criminal/Justice
  • Lab-Based
    • Professional POC
    • Home OTC
  • Market Analysis by Region
    • US
    • EUR
    • ROW
  • Competitive Analysis

CHAPTER FIVE: ISSUES AND TRENDS

  • Technology Trends
  • Drug Testing and Welfare Recipients
  • Drugs of Abuse Testing and Technologies Market iii
  • New Illicit Drugs
  • Drug Test Adulteration
  • Regulatory Issues
  • California
  • Colorado
  • Iowa
  • New York
  • Florida
  • Industry Consolidation
  • Drugs and Sports

CHAPTER SIX: INDUSTRY MANUFACTURERS

  • Overview
  • 1st Step Detect Associates, LLC
  • Abbott Diagnostics
  • AccuTech, LLC
  • Alere, Inc.
  • Alfa Scientific Designs, Inc
  • Amedica Biotech, Inc
  • American Bio Medica Corporation
  • Atlas Link Bioteck Co Ltd
  • Beckman Coulter, Inc
  • Biophor Diagnostics, Inc
  • Bio-Medical Products Corp
  • Bio-Rad Laboratories
  • BioScan Screening Sustems, Inc.
  • Branan Medical Corp
  • Confirm Biosciences
  • DeVon Medical Products
  • Identa Corp
  • Lifeloc Technologies
  • LifeSign, LLC
  • Mavand Solutions GmbH
  • MediTest DX
  • Mossman Associates
  • MP BioMedicals LLC
  • Nano-Ditech Corporation
  • Orasure Technologies, Inc
  • Ortho Clinical Diagnostics
  • Polymed Therapeutics Inc
  • PreChek Bio, Inc
  • Princeton Biomeditech Corporation
  • Psychemedics Corporation
  • Randox Laboratories Ltd
  • Redwood Toxicology Laboratory, Inc
  • Roche Diagnostics Corporation
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc
  • UCP Biosciences, Inc

APPENDIX: LIST OF MAJOR COMPANIES

TABLE OF FIGURES

CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1: Drugs of Abuse Testing and Technologies Market Analysis: 2011-2018
  • Figure 1-1: Drugs of Abuse Testing and Technologies Market Analysis: 2011-2018

CHAPTER TWO: INTRODUCTION

  • Table 2-1: Types of Inhalants
  • Table 2-2: Estimated World Population by Age and Geographical Region, 2012
  • Figure 2-1: Estimated World Population by Age and Geographical Region, 2012
  • Table 2-3: Annual Prevalence and Number of Illicit Drug Users Globally by Drug Type
  • Table 2-4: Estimated Number and Prevalence of Drug Users by Region and Age (15-64)

CHAPTER FOUR: DRUGS OF ABUSE MARKET AND COMPETITOR ANALYSIS

  • Table 4-1: Drugs of Abuse Testing and Technologies Market Analysis: 2011-2018
  • Figure 4-1: Drugs of Abuse Testing and Technologies Market Analysis: 2011-2018
  • Table 4-2: Drugs of Abuse Testing and Technologies Market Analysis by Test Type, 2013
  • Figure 4-2: Drugs of Abuse Testing and Technologies Market Analysis by Test Type, 2013
  • Table 4-3: Drugs of Abuse Testing and Technologies Market Analysis by Setting Type, 2013
  • Figure 4-3: Drugs of Abuse Testing and Technologies Market Analysis by Setting Type, 2013
  • Table 4-4: Drugs of Abuse Testing and Technologies Market Analysis by Region/Country, 2013
  • Figure 4-4: Drugs of Abuse Testing and Technologies Market Analysis by Region/Country, 2013
  • Table 4-5: Drugs of Abuse Testing and Technologies Market Revenues and Market Share of Leading Suppliers 2013
  • Figure 4-5: Drugs of Abuse Testing and Technologies Market Market Share by Leading Suppliers 2013

CHAPTER FIVE: ISSUES AND TRENDS

  • Table 5-1: Olympic Doping Cases 1968-2012

CHAPTER SIX: INDUSTRY MANUFACTURERS

Back to Top